Correlation between the expressions of circular RNAs in peripheral venous blood and clinicopathological features in hepatocellular carcinoma.

Circular RNAs (circRNAs) hepatocellular carcinoma (HCC) microvascular invasion (MVI) prothrombin induced by vitamin K absence-II (PIVKA-II)

Journal

Annals of translational medicine
ISSN: 2305-5839
Titre abrégé: Ann Transl Med
Pays: China
ID NLM: 101617978

Informations de publication

Date de publication:
Mar 2020
Historique:
entrez: 2 5 2020
pubmed: 2 5 2020
medline: 2 5 2020
Statut: ppublish

Résumé

Recent studies have reported that circular RNAs (circRNAs) are involved in the development of hepatocellular carcinoma (HCC). This study evaluated the expression of preoperative peripheral venous blood circRNAs in HCC patients and their predictive ability for microvascular invasion (MVI). Seven circRNAs (circMTO1, circ-10720, circZKSCAN1, cSMARCA5, circHIPK3, circSETD3 and ciRS-7) were screened from the literature as circRNAs with reported biological functions in HCC. The expression levels of seven circRNAs in preoperative blood samples and HCC tissues were detected by quantitative reverse transcription polymerase chain reaction. The correlations between the circRNA expressions in blood and the clinicopathological factors of HCC patients were analyzed. The risk factors of MVI were analyzed by univariate and multivariate logistic regression. The functional role of circSETD3 in cell migration and invasion was evaluated by wound healing and Transwell assays The expressions of all seven circRNAs were measured in peripheral venous blood samples. The venous expression levels of circHIPK3 and circMTO1 were significantly associated with gender, while circ-10720 and circMTO1 levels were significantly correlated with gross vascular invasion. Furthermore, circMTO1 and cSMARCA5 levels were significantly associated with alpha-fetoprotein level and ciRS-7 was significantly associated with satellite nodules. Importantly, low venous circSETD3 expression was significantly associated with prothrombin induced by vitamin K absence or antagonist-II (PIVKA-II) level, MVI, gross vascular invasion, and liver capsule. Furthermore, venous circSETD3 expression had predictive ability for MVI. Knockdown of circSETD3 promoted cell invasion and metastasis CircRNAs were stably present in peripheral venous blood and associated with multiple clinicopathological characteristics of HCC patients. Venous circSETD3 was an independent risk factor of MVI and shows ability to predict MVI in HCC patients before surgery.

Sections du résumé

BACKGROUND BACKGROUND
Recent studies have reported that circular RNAs (circRNAs) are involved in the development of hepatocellular carcinoma (HCC). This study evaluated the expression of preoperative peripheral venous blood circRNAs in HCC patients and their predictive ability for microvascular invasion (MVI).
METHODS METHODS
Seven circRNAs (circMTO1, circ-10720, circZKSCAN1, cSMARCA5, circHIPK3, circSETD3 and ciRS-7) were screened from the literature as circRNAs with reported biological functions in HCC. The expression levels of seven circRNAs in preoperative blood samples and HCC tissues were detected by quantitative reverse transcription polymerase chain reaction. The correlations between the circRNA expressions in blood and the clinicopathological factors of HCC patients were analyzed. The risk factors of MVI were analyzed by univariate and multivariate logistic regression. The functional role of circSETD3 in cell migration and invasion was evaluated by wound healing and Transwell assays
RESULTS RESULTS
The expressions of all seven circRNAs were measured in peripheral venous blood samples. The venous expression levels of circHIPK3 and circMTO1 were significantly associated with gender, while circ-10720 and circMTO1 levels were significantly correlated with gross vascular invasion. Furthermore, circMTO1 and cSMARCA5 levels were significantly associated with alpha-fetoprotein level and ciRS-7 was significantly associated with satellite nodules. Importantly, low venous circSETD3 expression was significantly associated with prothrombin induced by vitamin K absence or antagonist-II (PIVKA-II) level, MVI, gross vascular invasion, and liver capsule. Furthermore, venous circSETD3 expression had predictive ability for MVI. Knockdown of circSETD3 promoted cell invasion and metastasis
CONCLUSIONS CONCLUSIONS
CircRNAs were stably present in peripheral venous blood and associated with multiple clinicopathological characteristics of HCC patients. Venous circSETD3 was an independent risk factor of MVI and shows ability to predict MVI in HCC patients before surgery.

Identifiants

pubmed: 32355782
doi: 10.21037/atm.2020.02.134
pii: atm-08-06-338
pmc: PMC7186655
doi:

Types de publication

Journal Article

Langues

eng

Pagination

338

Informations de copyright

2020 Annals of Translational Medicine. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form and declare: The authors have no conflicts of interest to declare.

Références

Nat Rev Mol Cell Biol. 2016 Apr;17(4):205-11
pubmed: 26908011
Cancer Res. 2018 Aug 1;78(15):4150-4162
pubmed: 29844124
Ann Surg. 2011 Jul;254(1):108-13
pubmed: 21527845
Transl Oncol. 2014 Apr;7(2):248-55
pubmed: 24704092
Hepatology. 2019 May;69(5):2061-2075
pubmed: 30561769
J Exp Clin Cancer Res. 2018 Dec 4;37(1):300
pubmed: 30514341
J Surg Oncol. 2010 Oct 1;102(5):462-8
pubmed: 20872949
PLoS One. 2016 Jul 08;11(7):e0158347
pubmed: 27391479
World J Surg. 2010 May;34(5):1034-8
pubmed: 20127241
J Clin Lab Anal. 2018 Jun;32(5):e22379
pubmed: 29333615
Cell Physiol Biochem. 2017;44(3):967-981
pubmed: 29179180
RNA. 2013 Feb;19(2):141-57
pubmed: 23249747
Oncogene. 2019 Apr;38(15):2844-2859
pubmed: 30546088
Dis Markers. 2018 Jan 23;2018:3073467
pubmed: 29785229
Eur Radiol. 2019 Jun;29(6):2890-2901
pubmed: 30421015
BMC Cancer. 2018 Mar 12;18(1):278
pubmed: 29530006
Clin Gastroenterol Hepatol. 2019 Aug;17(9):1886-1893.e5
pubmed: 30557738
Cancer Lett. 2019 Feb 28;443:179-188
pubmed: 30529155
Hepatol Res. 2014 Aug;44(8):846-53
pubmed: 23834279
Oncogene. 2019 Apr;38(14):2516-2532
pubmed: 30531834
Gastroenterology. 2009 Sep;137(3):850-5
pubmed: 19524573
Mol Oncol. 2017 Apr;11(4):422-437
pubmed: 28211215
J Cell Physiol. 2019 Jul;234(7):11391-11400
pubmed: 30569515
Gut. 2014 May;63(5):844-55
pubmed: 24531850
Ann Surg. 2009 Jul;250(1):141-51
pubmed: 19561458
J Hepatol. 2018 Jun;68(6):1214-1227
pubmed: 29378234
Ann Surg Oncol. 2013 Jan;20(1):325-39
pubmed: 23149850
JAMA Surg. 2018 Oct 1;153(10):e182721
pubmed: 30073257
J Biol Chem. 2007 Mar 23;282(12):8741-8
pubmed: 17255102
J Clin Oncol. 2012 Oct 1;30(28):3525-32
pubmed: 22927533
Hepatology. 2017 Oct;66(4):1151-1164
pubmed: 28520103
J Exp Clin Cancer Res. 2019 Feb 22;38(1):98
pubmed: 30795787
Cell Physiol Biochem. 2018;51(5):2224-2236
pubmed: 30537731
Cell Death Dis. 2018 Feb 7;9(2):175
pubmed: 29415990
Genome Biol. 2018 Dec 11;19(1):218
pubmed: 30537986
J Hepatol. 2015 Apr;62(4):848-54
pubmed: 25450201
J Cancer Res Clin Oncol. 2017 Jan;143(1):17-27
pubmed: 27614453
Ann Surg Oncol. 2012 Jun;19(6):2027-34
pubmed: 22203184
Hepatology. 2019 Apr;69(4):1768-1786
pubmed: 30561826
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593

Auteurs

Peng Wang (P)

Department of Liver Surgery, West China Hospital, Sichuan University, Chengdu 610041, China.

Liang-Liang Xu (LL)

Department of Liver Surgery, West China Hospital, Sichuan University, Chengdu 610041, China.

Xiao-Bo Zheng (XB)

Department of Liver Surgery, West China Hospital, Sichuan University, Chengdu 610041, China.

Yi-Tao Hu (YT)

Department of Liver Surgery, West China Hospital, Sichuan University, Chengdu 610041, China.

Jin-Fu Zhang (JF)

Department of Liver Surgery, West China Hospital, Sichuan University, Chengdu 610041, China.

Sheng-Sheng Ren (SS)

Department of Liver Surgery, West China Hospital, Sichuan University, Chengdu 610041, China.

Xiang-Yong Hao (XY)

Department of Liver Surgery, West China Hospital, Sichuan University, Chengdu 610041, China.
Department of General Surgery, Gansu Provincial Hospital, Lanzhou 730000, China.

Lian Li (L)

Department of Liver Surgery, West China Hospital, Sichuan University, Chengdu 610041, China.

Ming Zhang (M)

Department of Liver Surgery, West China Hospital, Sichuan University, Chengdu 610041, China.
Department of General Surgery, Mianzhu Hospital of West China Hospital, Sichuan University, Mianzhu 618200, China.

Ming-Qing Xu (MQ)

Department of Liver Surgery, West China Hospital, Sichuan University, Chengdu 610041, China.

Classifications MeSH